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A Novel C-Terminal Domain of Drosophila PERIOD
Inhibits dCLOCK:CYCLE-Mediated Transcription
transcriptional activity through PAS domain interac-
tions.
Drosophila Schneider 2 (S2) cells are a useful system
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University of Massachusetts Medical Center
364 Plantation Street for testing this hypothesis because dCLK:CYC tran-
scriptional activation via E boxes (using transientlyWorcester, Massachusetts 01605
2 Program in Neuroscience transfected dClk and endogenously expressed cyc) and
PER:TIM inhibition of this activation can be reconstitu-Harvard Medical School
Boston, Massachusetts 02114 ted in these cells [8]. Previous S2 cell culture studies
utilized the coexpression of PER and TIM to inhibit
dCLK:CYC-mediated transcription because PER and
TIM appeared to be codependent for nuclear localiza-
tion [5] and robust inhibition of dCLK:CYC [8]. However,Summary
recent in vivo data indicate that PER in the absence of
TIM inhibits dCLK:CYC-mediated transcription [9] andThe essence of the Drosophila circadian clock involves
that TIM may not be essential for PER nuclear transportan autoregulatory feedback loop in which PERIOD
[3]. Accordingly, we reexamined the inhibitory activity(PER) and TIMELESS (TIM) inhibit their own transcrip-
of PER in an S2 cell transcriptional assay, alone, andtion by association with the transcriptional activators
with TIM at different plasmid concentrations (Figure 1).dCLOCK (dCLK) and CYCLE (CYC) [1]. Because PER,
Consistent with the idea that PER alone is sufficientdCLK, and CYC each contain a PAS domain [1], it
for inhibition of dCLK:CYC-mediated transcription, wehas been assumed that these interaction domains are
found that in S2 cells, PER without TIM inhibitedimportant for negative feedback. However, a critical
dCLK:CYC to more than 90% at high doses (100 ngrole for PAS-PAS interactions in Drosophila clock
and 600 ng; Figure 1). TIM without PER only modestlyfunction has not been shown. Nuclear transport of
inhibited dCLK:CYC, attaining maximal inhibition ofPER is also believed to be an essential regulatory step
40% (Figure 1). Consistent with previous work [8], TIMfor negative feedback [1–3], but this has not been di-
enhanced PER’s activity at low levels of PER (10 ngrectly tested, and the relevant nuclear localization se-
plasmid, the same concentration used earlier by othersquence (NLS) has not been functionally mapped. We
[8]), possibly by facilitating PER nuclear transport and/evaluated these critical aspects of PER-mediated tran-
or stability [1]. However, higher doses of PER may ex-scriptional inhibition in Drosophila Schneider 2 (S2)
ceed the capacity of cytoplasmic localization and/orcells. We mapped the dCLK:CYC inhibition domain
degradative mechanisms, allowing accumulation of(CCID) of PER and discovered that it lies in the C
enough nuclear PER to inhibit dCLK:CYC robustly, eventerminus, downstream of the PAS domain. Using dele-
in the absence of TIM. Thus by using high plasmid dosestion mutants and site-directed mutagenesis, we identi-
(200 ng) in subsequent experiments, we could studyfied a novel NLS in the CCID of PER that is a potent
PER’s inhibitory activity without dependence on TIMregulator of PER’s nuclear transport in S2 cells. We
binding sites for enhancement of PER nuclear transportfurther found that nuclear transport, primarily through
and/or stability. Furthermore, because V5-tagged PERthis novel NLS, is essential for the inhibitory activity
was found to be as effective as untagged PER for tran-of PER. The data indicate that nuclear PER inhibits
scriptional repression (Figure 1), we used V5-taggeddCLK:CYC-mediated transcription through a novel do-
constructs for the rest of our studies, facilitating themain that additionally contains a potent NLS.
determination of relative protein abundance and subcel-
lular location.
Results and Discussion
PER Inhibits dCLK:CYC Independent of TIM A Novel C-Terminal Domain in PER Inhibits
The PER:TIM complex is believed to inhibit dCLK:CYC dCLK:CYC-Mediated Transcription
through a direct physical interaction with the transcrip- To identify the region of PER responsible for inhibiting
tion factors, as suggested by in vitro gel shift assays dCLK:CYC-mediated transcription, we tested deletion
[4]. PER, dCLK, and CYC each possess a PAS domain mutants (at a plasmid dose of 200 ng) in the S2 cell
[1], consisting of two PAS motifs of approximately 50 transcription assay (Figure 2). All of the constructs stud-
amino acids each (PAS-A and PAS-B), a linker region ied yielded comparable levels of protein expression
between them, and a region downstream of PAS-B (data not shown). To our surprise, we found that frag-
called PAC, which in PER acts as a cytoplasmic localiza- ments containing the PAS domain did not inhibit
tion domain (CLD) [5]. PAS domains have been impli- dCLK:CYC whereas a PER fragment downstream of the
cated in protein-protein interactions [6], and indeed the PAS domain (PER 513–1224) possessed robust inhibi-
PAS domain of PER has been shown to bind TIM [7, 5]. tory activity. Using additional deletion mutants, we
Thus, it seemed likely that PER:TIM inhibits dCLK:CYC mapped the dCLK:CYC inhibition domain (CCID), de-
fined as the minimal region producing over 50% inhibi-
tion under the conditions tested, to amino acid residues*Correspondence: steven.reppert@umassmed.edu
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Figure 1. PER Alone Inhibits dCLK:CYC-Mediated Transcription in Figure 2. Mapping of the dCLK:CYC Inhibition Domain of PER
S2 Cells
S2 cells were transfected with 1 ng dClk and 200 ng or 10 ng of
The presence () or absence () of expression plasmids (1 ng dClk; per full-length or deletion mutant constructs. The luciferase activity
10 ng, 100 ng, or 600 ng of per, tim, or V5 epitope-tagged per (per- relative to the -galactosidase activity was computed and normal-
V5)) is depicted. CYC is expressed endogenously in S2 cells [8]. ized such that the mean value in the presence of dCLK alone was
The luciferase activity (expression driven by a minimal hsp70 pro- 100%. Each value is mean  SEM of three replicates. The numbers
moter and four per E boxes) relative to the -galactosidase activity associated with each mutant (illustrated schematically as bars) rep-
(expression driven by an actin promoter) was computed and normal- resent the amino acids of full-length PER (1224 aa) contained in
ized such that the mean value in the presence of dCLK alone was each mutant protein. PAS domain, white box; CLD, white box labeled
100%. Each value is mean  SEM of three replicates. The results “c”; CCID, black box in hatched region. The results shown are repre-
shown are representative of three independent experiments. sentative of three independent experiments.
764–1034 of PER (Figure 2; numbering according to the total number of cells examined for that construct was
1224 aa form of PER: splice variant A of the Canton-S calculated as a percentage. Full-length PER was primar-
strain, GenBank accession number P07663). Fragments ily cytoplasmic (in 69% of cells; Figure 3A; see Table
PER 764–1224 and PER 609–1034 had higher inhibitory S1 in the Supplemental Data available with this article
activity than PER 764–1034 (Figure 2), suggesting that online), consistent with observations by others [5].
flanking regions of the protein, although not essential, Moreover, we confirmed that a CLD was located be-
may enhance the inhibitory activity or the structural sta- tween amino acids 450 and 513 since the fragment PER
bility of the CCID. To ensure that the inhibition we ob- 1–450 had a greater degree of nuclear localization than
served was not artificially generated by overexpression did PER 1–516 (83% of cells stained in both cytoplasm
of our PER constructs, we retested PER 513–1224 at and nucleus versus 59% cyptoplasm only, respectively),
a lower dose (10 ng) and found that it still achieved and PER 513–1224 had a greater degree of nuclear local-
potent 70% inhibition (Figure 2). ization than did PER 447–1224 (91% nucleus only versus
57% both cytoplasm and nucleus, respectively; Figure
3A and Table S1).A Potent NLS Resides in the CCID of PER
We next examined both the CLD and functional nuclear Because the presence of a CLD in PER could obscure
the study of its NLSs and because there appear to belocalization sequences (NLSs) within PER because regu-
lated nuclear entry is thought to be an important compo- multiple NLSs, we analyzed NLS function in separate
PER deletion mutants, one that is upstream and one thatnent of the transcriptional feedback mechanism [1]. As
previously mentioned, PER has a CLD at the C-terminal is downstream of the CLD. In PER 1–450, we mutated the
basic amino acids in NLS73-7 to alanine (“1–450 M73-end of its PAS domain (residues 452–512) [5]. Sequence
analysis predicts that PER possesses at least two NLSs 7”), while in PER 513–1224, we mutated the basic amino
acids in NLS788-91 to alanine (“513–1224 M788-91”).of the classical basic monopartite variety: one near the
N terminus (aa 73–77; “NLS73-7”) [10] and one in the To our surprise, these mutations had only small effects
on subcellular localization (Figure 3A; Table S1).C-terminal half of the protein (aa 788–791; “NLS788-91”)
[11]. However, neither of the predicted NLSs has been We therefore assessed the localization of additional
deletion mutants. We found that a functional NLSverified to be a functional NLS.
We used immunocytochemistry to examine the sub- mapped to a C-terminal region between amino acids
813 and 840 (Figure 3A). Basic amino acids are charac-cellular localization of various V5-tagged PER deletion
mutants expressed in S2 cells. For each cell examined, teristic of classic NLSs recognized by importin-/ [12],
and, in this region, we found basic amino acids in twothe V5-tagged protein was classified as having one of
three staining patterns: nuclear (N), cytoplasmic (C), or clusters, 822–823 and 835–837, with a spacing (11 aa)
consistent with a classical bipartite NLS [12] (Figure 3A).both nuclear and cytoplasmic (B). Examples of each
staining pattern are shown in Figure 3B. The proportion When the basic amino acids in either of these clusters
were mutated to alanine in PER 513–1224 (generatingof cells in each category (N, C, or B) relative to the
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“PER 513–1224 M822-3” and “PER 513–1224 M835-7”),
the protein became predominantly cytoplasmic (Figures
3A and 3B; Table S1). Thus, PER has a functional bipar-
tite NLS in its C-terminal region within the CCID. It is
important to note that the N-terminal fragments of PER
(1–450 and its mutated counterpart, 1–450 M73-7) were
detectable in the nuclei of S2 cells (71%–83% stained
in both cytoplasm and nucleus; Figure 3A; Table S1),
suggesting the presence of secondary NLSs or N-ter-
minal binding sites with other proteins that could facili-
tate nuclear transport.
The combined cytoplasmic and nuclear presence of
a PAS-containing PER (1–450) fragment (Figures 3A and
3B) suggests that a lack of nuclear transport cannot
explain the failure of the PAS domain to inhibit
dCLK:CYC-mediated transcription. We confirmed that
the PER PAS domain does not inhibit transcription by
tagging PAS-containing N-terminal fragments of PER
(1–516 and 1–450) with a strong heterologous NLS (two
tandem repeats of the SV40 large T-antigen NLS,
DKKKRKV, which is a basic monopartite NLS). The NLS-
tagged PER 1–516 (which includes the PAS and CLD
domains) was found to be in both nucleus and cytoplasm
of 60% of transfected cells, while the NLS-tagged PER
1–450 (PAS domain without the CLD) was robustly nu-
clear (83% of cells; Figures 3B and 4; Table S1). When
tested in a transcription assay, these new constructs
were still unable to inhibit dCLK:CYC (Figure 4), indicat-
ing that the PAS domain does not possess inhibitory
activity.
Nuclear Presence of PER Is Essential for Inhibition
of dCLK:CYC Transcription
Although in vivo studies have correlated PER nuclear
entry with the inhibition of dCLK:CYC-mediated tran-
scription [2, 3], it has not been shown whether PER must
be nuclear to mediate transcriptional inhibition. In fact,
it has been suggested that cytoplasmic PER:TIM could
inhibit dCLK:CYC by sequestering one or both of the
transcription factors in the cytoplasm, a scenario dem-
onstrated for other transcription factors [4]. The ability
of PER alone to inhibit dCLK:CYC in S2 cells, despite
its primarily cytoplasmic localization (Figures 1 and 3),
is consistent with the cytoplasmic sequestering idea.
Figure 3. Mapping a Novel Nuclear Localization Sequence To examine whether nuclear entry is indeed necessary
V5-tagged per constructs (ca. 300 ng) were transfected into S2 cells for PER’s inhibitory activity, we further evaluated the
and the cellular location of their protein products was assayed by NLS mutant constructs of PER 513–1224 (PER 513–1224
immunocytochemistry using a monoclonal anti-V5 primary antibody
M822-3 and M835-7). We found that the NLS mutantand a Cy3-conjugated secondary antibody. The cells were also DAPI
proteins, which were cytoplasmic in 80% of trans-stained to visualize the nuclei.
(A) For each cell examined, the V5-tagged protein was classified as fected cells (Figures 3 and 4; Table S1), failed to inhibit
having one of three staining patterns: nuclear (N), cytoplasmic (C), dCLK:CYC-mediated transcription, suggesting that the
or both nuclear and cytoplasmic (B). For each construct, the propor- nuclear presence of the PER CCID is required for tran-
tion of cells in each category (N, C, or B) relative to the total number of scriptional inhibition (Figure 4). However, because the
cells examined was calculated as a percentage; the immunostaining
NLS is internal to the CCID, it remained possible thatpattern (N, C, or B) of50% of cells examined is shown in the right-
hand column, and the percentage of cells with that staining pattern
is shown in parentheses (complete data are given in Table S1).
The vertical dashed lines indicate the NLS-containing region (aa
(B) Representative subcellular staining patterns of PER constructs.813–840) determined using deletion mutants. The sequence of this
region is shown below the constructs. The basic amino acids (lysine, Cy3 (red) and DAPI (blue) signals were imaged separately (first and
second rows of images, respectively) using wavelength-selectiveK; arginine, R; histidine, H) are underlined, mutations to alanine are
indicated above the sequence, and functional components of the filters on a fluorescence microscope and digitally merged (overlap
is magenta; bottom row of images) using the Metamorph softwarebipartite NLSs, as shown by mutagenesis, are indicated below the
sequence. PAS domain, white box; CLD, white box labeled “c”; package (Universal Imaging Corp.). “ NLS” denotes constructs
tagged with two SV40 large T-antigen NLSs.CCID, black box; mutagenized putative NLS, “X.”
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Figure 4. Nuclear Presence of the CCID Is
Required for PER Inhibition of dCLK:CYC-
Mediated Transcription
V5-tagged per constructs (left column) were
assayed for inhibition of dCLK:CYC-medi-
ated transcription (middle column) and cellu-
lar location via immunocytochemistry (right
column). Transcription assays used 1 ng dClk
and 200 ng or 10 ng of the per constructs.
The luciferase activity relative to the -galac-
tosidase activity was computed and normal-
ized such that the mean value in the presence
of dCLK alone was 100%. Each value is
mean  SEM of three replicates. For each
cell examined by immunocytochemistry, the
V5-tagged protein was classified as having
one of three staining patterns: nuclear (N),
cytoplasmic (C), or both nuclear and cyto-
plasmic (B). For each construct, the propor-
tion of cells in each category (N, C, or B) rela-
tive to the total number of cells examined was
calculated as a percentage; the immunostain-
ing pattern (N, C, or B) of 50% of cells ex-
amined is shown in the right column, and the percentage of cells with that staining pattern is shown in parentheses (complete data are given
in Table S1). The immunocytochemical data in bold have been duplicated from Figure 3. PAS domain, white box; CLD, white box labeled “c”;
CCID, black box; mutagenized NLS, “X”; SV40 large T-antigen NLS (DKKKRKV) 	 2, circles. The results shown are representative of three
independent experiments.
the NLS mutations disrupted the structure of the CCID 764–1034) responsible for transcriptional inhibitory ac-
tivity (Figures 2 and 5). The functional importance of thisin addition to preventing nuclear transport. We thus tried
to rescue inhibitory activity by tagging the C terminus C-terminal region of PER is corroborated by an earlier
in vivo experiment, in which a per transgene extendingof the NLS mutant constructs with SV40 large T-antigen
NLSs. Not only were these new constructs robustly nu- only up to amino acid 876 failed to rescue behavioral
rhythms in per null mutant (per01) flies [13]. This truncatedclear, but they now inhibited dCLK:CYC as effectively
as the wild-type PER 513–1224, indicating that the NLS PER would still possess binding sites for TIM [5, 7],
DOUBLE-TIME [14], and CRYPTOCHROME [15], but, asmutations did not disrupt CCID structure (Figures 3B
and 4; Table S1). We obtained similar results with low our experiments reveal, its CCID would be disrupted
(Figure 5). We also found that the monopartite NLSsdoses (10 ng) of the NLS-tagged and untagged PER
513–1224 mutant and wild-type plasmids (Figure 4). The previously predicted by sequence analysis are relatively
weak in regulating PER localization. Instead, a novel,dependence of PER’s inhibitory activity on nuclear pres-
ence explains why the robustly nuclear PER 513–1224 is bipartite NLS in the CCID is the dominant NLS in S2
cells (Figure 3A). However, there may be several NLSsmore effective at inhibiting dCLK:CYC than comparable
doses of primarily cytoplasmic, full-length PER (Figure that contribute to PER nuclear transport in vivo since
transgenic fly experiments suggest that there is a com-2). We conclude that the nuclear presence of PER (or a
PER fragment containing the CCID) is essential for its petent NLS in the first 95 amino acids of PER [16], and
N-terminal fragments of PER do show some nuclearinhibitory action on dCLK:CYC-mediated transcription.
localization in S2 cells (Figure 3A). We further demon-
strated that the nuclear transport of PER is essentialConclusions
for its inhibition of dCLK:CYC-mediated transcriptionWe found that a key step in the Drosophila circadian
(Figure 4), as suggested by earlier work [2, 3]. Thesenegative feedback loop, PER inhibition of dCLK:CYC
results advance our understanding of PER function andtranscription, is not mediated by the PAS domain of PER.
thus our understanding of the Drosophila circadianInstead, we discovered that the previously uncharted C
terminus of PER contains a novel domain (CCID; aa clock mechanism.
Figure 5. PER Subdivisions and Functional
Domains
PAS domain, white box with the PAS-A (“A”),
PAS-B (“B”), and CLD “C” indicated; CCID,
black box; glycine-threonine repeat, box with
the letter “G.” Brackets above PER indicate
sites of demonstrated interaction with other
clock proteins: DBT 
 DOUBLE-TIME [14],
TIM 
 TIMELESS [5, 7], CRY 
 dCRYPTO-
CHROME [15], and CCID 
 dCLK:CYC inhibitory domain (Figure 2). The arrow indicates the location of amino acid 876; a transgene truncated
at this residue fails to rescue behavioral rhythms in per01 mutant flies [13]. Black lines underneath PER indicate the regions conserved in PER
proteins of other insect species: C1 through C6, as defined by Colot and colleagues [17].
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